Pharmacoeconomic analysis of cellex application in the treatment of cerebrovascular accident
A pharmacoeconomic study of cerebrovascular accident treatment with Cellex was conducted at the background of routine clinical practices in comparison with routine clinical practices only. It was found that in the first case the therapy is dominant in comparison with the second one as it shows better therapeutic effectiveness and is characterized by a lower cost-effectiveness ratio. It was also defined that transfer of one patient from routine clinical practices to Cellex treatment at the background of routine clinical practices is supported with the economy of 7 313 rubles.
Скорее всего ваш браузер не поддерживает PDF и Adobe Reader, нажмите здесь, чтобы просмотреть PDF